Microbial Contaminant Control Problems at Ozempic Manufacturing Facility Has Resulted in FDA Investigator Warning
A new report reveals FDA inspectors found a lack of adequate microbial controls at a Novo Nordisk plant in the U.S., which manufactures the active ingredient for Ozempic and Wegovy.